Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma and Vetter announced that the companies are unveiling Xpert Alliance, a joint visualization of their strategic collaboration.
read more
Rentschler Biopharma SE and Ikarovec announced that the two companies have entered into a collaboration.
read more
Tuesday, December 02, 2025
Rentschler Biopharma and Coriolis Pharma announced a strategic collaboration which will offer seamless, end-to-end solutions from early formulation through to commercial manufacturing, combining their complementary expertise to accelerate product’s ...
read more
Thursday, February 13, 2020
Rentschler Biopharma announced the hiring of Grace Kim as Vice President Business Development – North America and APAC.
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) today provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including...
read more
RenovaCare has expanded its engagement with MCRA to continue to advance the Company’s FDA program.
read more
RenovaCare announced its Chairman, Chief Executive Officer, and President, Alan Rubino, has decided to retire.
read more
Wednesday, April 10, 2019
ReNeuron has signed a license agreement with Shanghai Fosun Pharmaceutical for the development, manufacture and commercialization of ReNeuron's CTX and hRPC cell therapy programs in China.
read more
Tuesday, September 03, 2024
Renaissance Lakewood announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
read more
Renaissance Acquisition Holdings, LLC (“Renaissance”), a portfolio company of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has ...
read more
Thursday, December 14, 2017
reMYND and Novo Nordisk have entered into a license agreement to further develop reMYND's ReS39 therapeutic program of diabetes.
read more
Fresenius Kabi announced today the immediate availability in the United States of Remifentanil Hydrochloride for Injection.
read more
Wednesday, September 26, 2018
As we all know, compounding can play an important role in patient care, but because compounded drug products are not reviewed by FDA for safety, effectiveness, or quality before they are marketed, they should be used only when necessary to meet ...
read more
Relief and NeuroRx announced NeuroRx has completed final manufacturing of intravenous RLF-100 as a potential treatment for COVID-19 ventilated patients with ARDS.
read more
Relief and Acer announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.
read more